{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:11:57Z","timestamp":1784340717419,"version":"3.55.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>COVID-19 infection has had a profound impact on society. During the initial phase of the pandemic, there were several suggestions that COVID-19 may lead to acute and protracted neurologic sequelae. For example, peripheral neuropathies exhibited distinctive features as compared to those observed in critical care illness. The peripheral nervous system, lacking the protection afforded by the blood\u2013brain barrier, has been a particular site of sequelae and complications subsequent to COVID-19 infection, including Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy. We will discuss these disorders in terms of their clinical manifestations, diagnosis, and treatment as well as the pathophysiology in relation to COVID-19.<\/jats:p>","DOI":"10.3389\/fnins.2023.1198327","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T05:37:42Z","timestamp":1693460262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Francisco","family":"Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashir","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ensrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Laudanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s12026-022-09316-6","article-title":"Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review","volume":"70","author":"Abolmaali","year":"2022","journal-title":"Immunol. Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/mus.27458","article-title":"Small fiber neuropathy associated with SARS-CoV -2 infection","volume":"65","author":"Abrams","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh","year":"2020","journal-title":"J. Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e29704","DOI":"10.1097\/MD.0000000000029704","article-title":"COVID-19 and Guillain-Barr\u00e9 syndrome: a single-center prospective case series with a 1-year follow-up","volume":"101","author":"Ahmad","year":"2022","journal-title":"Medicine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/cjn.2021.102","article-title":"Guillain Barre syndrome as a complication of COVID-19: a systematic review","volume":"49","author":"Aladawi","year":"2022","journal-title":"Can. J. Neurol. Sci."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/mus.26918","article-title":"COVID-19 in patients with myasthenia gravis","volume":"62","author":"Anand","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1111\/ene.14721","article-title":"Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection","volume":"28","author":"Assini","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s00134-022-06793-z","article-title":"Plasma exchange in the intensive care unit: a narrative review","volume":"48","author":"Bauer","year":"2022","journal-title":"Intensive Care Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00415-016-8204-2","article-title":"Proximal nerve lesions in early Guillain-Barr\u00e9 syndrome: implications for pathogenesis and disease classification","volume":"264","author":"Berciano","year":"2017","journal-title":"J. Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/CND.0000000000000154","article-title":"Diagnostic criteria for small Fiber neuropathy","volume":"18","author":"Blackmore","year":"2017","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"Bubuioc","year":"2021","journal-title":"J. Med. Life"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000524205","article-title":"Small-Fiber neuropathy possibly associated with COVID-19","volume":"14","author":"Burakgazi","year":"2022","journal-title":"Case Rep. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"ofaa102","DOI":"10.1093\/ofid\/ofaa102","article-title":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019","volume":"7","author":"Cao","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19\u2013associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnut.2022.809823","article-title":"On therapeutic plasma exchange against severe COVID-19-associated pneumonia: an observational clinical study","volume":"9","author":"Cegolon","year":"2022","journal-title":"Front. Nutr."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","article-title":"Dysautonomia in Guillain\u2013Barr\u00e9 syndrome: prevalence, clinical Spectrum, and outcomes","volume":"32","author":"Chakraborty","year":"2019","journal-title":"Neurocrit. Care"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"836826","DOI":"10.3389\/fmed.2021.836826","article-title":"Viral load in COVID-19 patients: implications for prognosis and vaccine efficacy in the context of emerging SARS-CoV-2 variants","volume":"8","author":"da Silva","year":"2021","journal-title":"Front. Med."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1085-9489.2006.00062.x","article-title":"Acute steroid responsive small-fiber sensory neuropathy: a new entity?","volume":"11","author":"Dabby","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/14737175.2020.1794825","article-title":"Clinical diagnosis and management of small fiber neuropathy: an update on best practice","volume":"20","author":"Devigili","year":"2020","journal-title":"Expert. Rev. Neurother."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.26355\/eurrev_202004_20875","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e244102","DOI":"10.1136\/bcr-2021-244102","article-title":"Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection","volume":"14","author":"Essajee","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"106334","DOI":"10.1016\/j.ijantimicag.2021.106334","article-title":"Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial","volume":"57","author":"Faqihi","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11910-019-1020-1","article-title":"Current diagnosis and treatment of painful small Fiber neuropathy","volume":"19","author":"Farhad","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1111\/ene.15348","article-title":"Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: a multicenter experience","volume":"29","author":"Farina","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol. clini."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.transci.2019.04.007","article-title":"Therapeutic plasma exchange: review of current indications","volume":"58","author":"Fern\u00e1ndez-Zarzoso","year":"2019","journal-title":"Transfus. Apher. Sci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"100064","DOI":"10.1016\/j.clinsp.2022.100064","article-title":"SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome","volume":"77","author":"Finsterer","year":"2022","journal-title":"Clinics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1590\/0004-282X-ANP-2021-0030","article-title":"Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the intensive care unit","volume":"79","author":"FINSTERER","year":"2021","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2013","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ana.25987","article-title":"Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in Covid-19","volume":"89","author":"Fragiel","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s10020-022-00553-x","article-title":"Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: a phase 2\/3 randomized controlled trial","volume":"28","author":"Fragoso-Saavedra","year":"2022","journal-title":"Mol. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"103598","DOI":"10.1016\/j.transci.2022.103598","article-title":"Plasma exchange and COVID 19","volume":"61","author":"Ginikopoulou","year":"2022","journal-title":"Transfus. Apher. Sci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","article-title":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study","volume":"24","author":"Gucyetmez","year":"2020","journal-title":"Crit. Care"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"Neurology"},{"key":"ref36","volume-title":"Guillain-Barr\u00e9 Syndrome Concerns [Internet]","year":"2019"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","article-title":"Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19","volume":"181","author":"Gupta","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jca.21331","article-title":"Neurologic indications for therapeutic plasma exchange: 2013 update","volume":"29","author":"Gwathmey","year":"2014","journal-title":"J. Clin. Apher."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e228879","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the vaccine safety datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious onset of myasthenia gravis in a COVID-19 patient","volume":"11","author":"Huber","year":"2020","journal-title":"Front. Neurol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"914411","DOI":"10.3389\/fneur.2022.914411","article-title":"Neuromuscular complications of SARS-CoV-2 and other viral infections","volume":"13","author":"Jacob","year":"2022","journal-title":"Front. Neurol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e2236","DOI":"10.1212\/WNL.0000000000012894","article-title":"Small fiber neuropathy incidence, prevalence, longitudinal impairments, and disability","volume":"97","author":"Johnson","year":"2021","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.08.013","article-title":"MMP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology","volume":"181","author":"Jovanova-Nesic","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e0244853","DOI":"10.1371\/journal.pone.0244853","article-title":"Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study","volume":"16","author":"Kamran","year":"2021","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e245455","DOI":"10.1136\/bcr-2021-245455","article-title":"Guillain-Barre syndrome (GBS) associated with COVID-19 infection that resolved without treatment in a child","volume":"15","author":"Kanou","year":"2022","journal-title":"BMJ Case Rep."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"703","DOI":"10.32598\/bcn.2021.3565.1","article-title":"Guillain-Barre syndrome and COVID-19 vaccine: a report of nine patients","volume":"12","author":"Karimi","year":"2021","journal-title":"Basic Clin. Neurosci."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"106834","DOI":"10.1016\/j.clineuro.2021.106834","article-title":"Myasthenia gravis associated with novel coronavirus 2019 infection: a report of three cases","volume":"208","author":"Karimi","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie","year":"2021","journal-title":"Brain"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijid.2020.06.064","article-title":"Therapeutic plasma exchange in adults with severe COVID-19 infection","volume":"99","author":"Khamis","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41582-020-0385-8","article-title":"Neurological immunotherapy in the era of COVID-19 \u2014 looking for consensus in the literature","volume":"16","author":"Korsukewitz","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41577-020-00458-y","article-title":"Do cross-reactive antibodies cause neuropathology in COVID-19?","volume":"20","author":"Kreye","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biomed1010006","article-title":"Guillain\u2013Barr\u00e9 syndrome in COVID-19\u2014the potential role of NCAM-1 and immunotherapy","volume":"1","author":"Laudanski","year":"2021","journal-title":"Bio. Med."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3346\/jkms.2022.37.e50","article-title":"Early-onset myasthenia gravis following COVID-19 vaccination","volume":"37","author":"Lee","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain\u2013Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/jca.21883","article-title":"The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: a critical appraisal of the current evidence","volume":"36","author":"Lu","year":"2021","journal-title":"J. Clin. Apher."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism","volume":"25","author":"Lucchese","year":"2020","journal-title":"Cell Stress Chaperones."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/neurolint14020033","article-title":"Impact of COVID-19 in AChR myasthenia gravis and the safety of vaccines: data from an Italian cohort","volume":"14","author":"Lupica","year":"2022","journal-title":"Neurol. Int."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e2397","DOI":"10.1002\/rmv.2397","article-title":"Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: a systematic review and meta-analysis","volume":"32","author":"Marcec","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref59","first-page":"9","article-title":"Case series: post-COVID small fiber neuropathy","volume":"98","author":"McAlpine","year":"2022","journal-title":"Neurol. Int."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the guidelines of the German neurological society","volume":"263","author":"Melzer","year":"2016","journal-title":"J. Neurol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1007\/s10072-022-05922-2","article-title":"Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab","volume":"43","author":"Mimori","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"110342","DOI":"10.1016\/j.mehy.2020.110342","article-title":"NCAM protein and SARS-COV-2 surface proteins: in-silico hypothetical evidence for the immunopathogenesis of Guillain-Barr\u00e9 syndrome","volume":"145","author":"Morsy","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","article-title":"Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients","volume":"19","author":"Nelke","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/MOH.0000000000000609","article-title":"New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases","volume":"27","author":"Norris","year":"2020","journal-title":"Curr. Opin. Hematol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.ensci.2020.100276","article-title":"Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report","volume":"21","author":"Novak","year":"2020","journal-title":"eNeurologicalSci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e1146","DOI":"10.1212\/NXI.0000000000001146","article-title":"Peripheral neuropathy evaluations of patients with prolonged long COVID","volume":"9","author":"Oaklander","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jamaneurol.2019.2917","article-title":"Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review","volume":"76","author":"Oaklander","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat. Med."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/WNL.0b013e3182a8236e","article-title":"Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands","volume":"81","author":"Peters","year":"2013","journal-title":"Neurol. Int."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"100578","DOI":"10.1016\/j.bbih.2022.100578","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with COVID-19: a systematic review","volume":"28","author":"Pimentel","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijid.2022.06.014","article-title":"Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis","volume":"122","author":"Qin","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e17945","DOI":"10.7759\/cureus.17945","article-title":"Pharyngeal-cervical-brachial variant of Guillain-Barr\u00e9 syndrome in a patient of COVID-19 infection","volume":"13","author":"Randhawa","year":"2021","journal-title":"Cureus"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s10072-021-05823-w","article-title":"Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review","volume":"43","author":"Rodrigues","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/vaccines9101112","article-title":"COVID-19 vaccination in patients with myasthenia gravis: a single-center case series","volume":"9","author":"Ruan","year":"2021","journal-title":"Vaccines"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"e0261113","DOI":"10.1371\/journal.pone.0261113","article-title":"Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: retrospective cohort study","volume":"16","author":"Ruggenenti","year":"2021","journal-title":"PLoS One"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurol. Int."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1007\/s00415-022-11140-9","article-title":"Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients","volume":"269","author":"Sansone","year":"2022","journal-title":"J. Neurol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States, 1976\u201319771","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am. J. Epidemiol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jbspin.2017.11.002","article-title":"Small fiber neuropathy: diagnosis, causes, and treatment","volume":"85","author":"S\u00e8ne","year":"2018","journal-title":"Joint Bone Spine"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e2789","DOI":"10.1002\/brb3.2789","article-title":"COVID-19 and myasthenia gravis: a review of neurological implications of the SARS-COV-2","volume":"12","author":"Shah","year":"2022","journal-title":"Brain Behav."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"608130","DOI":"10.3389\/fphar.2021.608130","article-title":"Intensive care and treatment of severe Guillain\u2013Barr\u00e9 syndrome","volume":"12","author":"Shang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1007\/s00415-020-09742-2","article-title":"Axonal variants of Guillain-Barr\u00e9 syndrome: an update","volume":"268","author":"Shang","year":"2021","journal-title":"J. Neurol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"108384","DOI":"10.1016\/j.clim.2020.108384","article-title":"Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy","volume":"214","author":"Shoenfeld","year":"2020","journal-title":"Clini. Immunol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10286-021-00803-8","article-title":"Autonomic dysfunction following COVID-19 infection: an early experience","volume":"31","author":"Shouman","year":"2021","journal-title":"Clin. Auton. Res."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jns.12298","article-title":"Small-fiber neuropathy: expanding the clinical pain universe","volume":"24","author":"Sopacua","year":"2019","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"117263","DOI":"10.1016\/j.jns.2020.117263","article-title":"Guillain Barr\u00e9 syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series","volume":"420","author":"Sriwastava","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","volume":"268","author":"Sriwastava","year":"2020","journal-title":"J. Neurol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 global rheumatology Alliance physician-reported registry","volume":"80","author":"Strangfeld","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/WCO.0000000000000970","article-title":"Neuromuscular complications of coronavirus disease-19","volume":"34","author":"Suh","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1212\/WNL.0000000000012344","article-title":"Skeletal muscle and peripheral nerve histopathology in COVID-19","volume":"97","author":"Suh","year":"2021","journal-title":"Neurol. Int."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jns.12482","article-title":"COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era","volume":"27","author":"Taga","year":"2022","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s41983-022-00516-3","article-title":"The relationship between myasthenia gravis and COVID-19: a systematic review","volume":"58","author":"Tugasworo","year":"2022","journal-title":"Egypt. J. Neurol. Psychiatr. Neurosurg."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mus.27251","article-title":"Post COVID-19 vaccine small fiber neuropathy","volume":"64","author":"Waheed","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccine"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"107732","DOI":"10.1016\/j.intimp.2021.107732","article-title":"Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): a meta-analysis","volume":"96","author":"Xiang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1055\/s-0039-1688977","article-title":"Small Fiber neuropathy","volume":"39","author":"Zhou","year":"2019","journal-title":"Semin. Neurol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"496","DOI":"10.20471\/acc.2021.60.03.21","article-title":"Treatment of myasthenia gravis patients with COVID-19: review of the literature","volume":"60","author":"\u017dupani\u0107","year":"2021","journal-title":"Acta Clin. Croat."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1198327\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T05:37:49Z","timestamp":1693460269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1198327\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":105,"alternative-id":["10.3389\/fnins.2023.1198327"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1198327","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"article-number":"1198327"}}